NT79: A Novel Neurotensin Receptor Agonist with Selective Behavioral Effects

被引:0
|
作者
Boules, Mona M. [1 ]
Liang, Yanqi [1 ]
Oliveros, Alfredo [1 ]
Fauq, Irfan [1 ]
Wilson, Mina [1 ]
Khaniyev, Shaheen [1 ]
Williams, Katrina [1 ]
Barbut, Denise [2 ]
Richelson, Elliott [1 ]
机构
[1] Mayo Clin, Jacksonville, FL 32224 USA
[2] Sarentis Therapeut Inc, Res, New York, NY USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
232
引用
收藏
页码:71S / 71S
页数:1
相关论文
共 50 条
  • [41] BEHAVIORAL-EFFECTS OF RO-41-9067 - A NOVEL DA D2 RECEPTOR AGONIST
    PUGLISIALLEGRA, S
    CABIB, S
    BELZUNG, C
    PSYCHOPHARMACOLOGY, 1990, 101 : S46 - S46
  • [42] Antidepressant effects of pramipexole, a novel dopamine receptor agonist
    J. Maj
    Z. Rogóż
    G. Skuza
    K. Kołodziejczyk
    Journal of Neural Transmission, 1997, 104 : 525 - 533
  • [43] BEHAVIORAL-EFFECTS OF RO-41-9067 - A NOVEL D2 DOPAMINE RECEPTOR AGONIST
    BELZUNG, C
    CARLETTI, P
    ANGELUCCI, F
    PUGLISIALLEGRA, S
    CABIB, S
    DRUG DEVELOPMENT RESEARCH, 1992, 27 (04) : 425 - 433
  • [44] The effects of a novel δ-opioid receptor agonist on micturition in rats
    Watson, MJ
    Gengo, PJ
    Pendergast, W
    Chang, J
    Wei, VK
    Sanford, IA
    Millard, DB
    Chang, KJ
    FASEB JOURNAL, 2004, 18 (05): : A960 - A960
  • [45] Clinical pharmacology of tanaproget, a novel selective nonsteroidal progesterone receptor agonist
    Bapst, JL
    Orczyk, GP
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 14S - 14S
  • [46] Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
    Shekhar, Anantha
    Potter, William Z.
    Lightfoot, Jeffrey
    Lienemann, John
    Dube, Sanjay
    Mallinckrodt, Craig
    Bymaster, Frank P.
    McKinzie, David L.
    Felder, Christian C.
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (08): : 1033 - 1039
  • [47] EFFECTS OF SR-48692, A SELECTIVE NONPEPTIDE NEUROTENSIN RECEPTOR ANTAGONIST, ON 2 DOPAMINE-DEPENDENT BEHAVIORAL-RESPONSES IN MICE AND RATS
    PONCELET, M
    SOUILHAC, J
    GUEUDET, C
    TERRANOVA, JP
    GULLY, D
    LEFUR, G
    SOUBRIE, P
    PSYCHOPHARMACOLOGY, 1994, 116 (02) : 237 - 241
  • [48] The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance
    Feifel, David
    Melendez, Gilia
    Murray, Rachel J.
    Tran, Dan N. Tina
    Rullan, Michelle A.
    Shilling, Paul D.
    PSYCHOPHARMACOLOGY, 2008, 200 (02) : 197 - 203
  • [49] The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance
    David Feifel
    Gilia Melendez
    Rachel J. Murray
    Dan N. Tina Tran
    Michelle A. Rullan
    Paul D. Shilling
    Psychopharmacology, 2008, 200
  • [50] Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model
    Omote, K
    Kawamata, T
    Nakayama, Y
    Yamamoto, H
    Kawamata, M
    Namiki, A
    ANESTHESIOLOGY, 2002, 97 (01) : 170 - 176